Skip to main content

WellDoc

By Dave Muoio | 05:31 pm | December 12, 2019
The pharmacy benefit manager has vetted 15 programs from Livongo, Propeller Health, Omada Health and others to help clients choose effective digital health management tools.
By Dave Muoio | 04:25 pm | November 17, 2019
Forest Devices' system, which employs disposable EEG caps and AI to streamline stroke care, was highlighted by judges and audience members over the cardiac offerings of fellow finalists Welldoc, PhysIQ, Happify Health, Qura and VUNO.
By Dave Muoio | 12:33 pm | May 03, 2019
Also: Microsoft and Imprivata developing healthcare access management platform; SyncThink pairs with QuesGen Systems.
By Laura Lovett | 11:25 am | September 07, 2018
Also in hires: Voice assistant AI startup Notable appoints VC partner Annie Lamont to its board, and DarioHealth taps Olivier Jarry as its next CCO and president. 
By Jonah Comstock | 04:19 pm | July 09, 2018
WellDoc has expanded its BlueStar digital diabetes management platform to include a weight loss feature and a feature for those with both diabetes and hypertension.
By Laura Lovett | 03:19 pm | July 02, 2018
The NHS is looking to ramp up its patient data security, after signing a contract with software company Privitar for its de-identification technology.
By Dave Muoio | 12:17 pm | April 18, 2018
Novo Nordisk and San Francisco-based Sempre Health have announced their collaboration on a pilot program that will offer diabetes medications through the latter company’s monetary incentive and SMS-driven prescription refill platform.
By Dave Muoio | 03:50 pm | March 06, 2018
Samsung Health users will now have access to a new consumer-grade version of WellDoc’s digital diabetes management platform, the two companies announced this morning.
By Laura Lovett | 11:21 am | January 17, 2018
WellDoc’s digital diabetes management therapeutic BlueStar will now be available on the Solera network as a diabetes management option.
By Jonah Comstock | 04:03 pm | January 11, 2018
Correction: A previous version of this story mistated the projected timeline for the combined product.